​

On April 9, 2024, Antibe Therapeutics Inc. ("Antibe" or the "Company"), initiated proceedings (the "CCAA Proceedings") under the Companies Creditors Arrangements Act (“CCAA").

On the same day, the Ontario Superior Court of Justice (the “Court") granted an Initial Order which, among other things: (i) granted a stay of proceedings up to and including April 18, 2024; and (ii) appointed Deloitte Restructuring Inc. as Court-appointed monitor of the business and financial affairs of Antibe (in such capacity, the “Monitor").  

If you have any questions regarding this matter, please contact Deloitte Restructuring Inc. at the following address:

Deloitte Restructuring Inc.
8 Adelaide Street West, Suite 200
Toronto, ON   M5H 0A9
Canada

Attention: Martin Lin, Manager

Telephone:  416-874-3874
Fax: 416-601-6151
Email: antibe@deloitte.ca